Albert Labs International (XCNQ:ABRT) Receivables Turnover : 0.00 (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Albert Labs International's Revenue for the three months ended in Sep. 2023 was C$0.00 Mil. Albert Labs International's average Accounts Receivable for the three months ended in Sep. 2023 was C$0.00 Mil.

Albert Labs International Receivables Turnover Historical Data

The historical data trend for Albert Labs International's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Receivables Turnover Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Receivables Turnover

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Receivables Turnover	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Albert Labs International's Receivables Turnover

For the Biotechnology subindustry, Albert Labs International's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Albert Labs International's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Receivables Turnover falls into.

Albert Labs International Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Albert Labs International's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Receivables Turnover (A: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2022 )	/ (	(Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Albert Labs International's Receivables Turnover for the quarter that ended in Sep. 2023 is calculated as

	Receivables Turnover (Q: Sep. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2023 )	/ (	(Accounts Receivable (Q: Jun. 2023 )	+	Accounts Receivable (Q: Sep. 2023 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Albert Labs International (XCNQ:ABRT) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Albert Labs International Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International Headlines

No Headlines